The 72 rating InvestorsObserver gives to Amicus Therapeutics, Inc. (FOLD) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 83 percent of stocks in the Biotechnology industry, FOLD’s 72 overall rating means the stock scores better than 72 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
Does Amicus Therapeutics, Inc. (FOLD) Have What it Takes to be in Your Portfolio Thursday?
FOLD has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on FOLD!